The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
Frequently asked questions
What is the Amplify ETF Trust (THNR) expense ratio?
The Amplify ETF Trust funds expense ratio is 0.59%.
What is Amplify ETF Trust (THNR) current stock price?
As of the latest data, Amplify ETF Trust stock price is $24.66, with a previous close of $24.70. Amplify ETF Trust lost -$0.04 in the last trading session, representing a -0.16% loss.
Does Amplify ETF Trust (THNR) pay dividends?
Yes. Amplify ETF Trust pays annual dividends with an annualized yield of 1.67% and an estimated annual payout of $0.41 per share.
